Asymchem Announces Opening of High Potency API and Drug Product Facility
Posted on: Wednesday, 20 May 2009, 09:02 CDT
Facility Open as of
TEDA
This dedicated facility is sited at Asymchem's TEDA Tianjin 1 location, and provides state-of-the art containment for production of potent API's, as well as tablet and capsule manufacturing that incorporate potent ingredients. The new facility allows Asymchem to operate two separate API manufacturing trains of 50 and 100L, as well as additional facilities for smaller-scale research and production and oral dosage form manufacturing.
"We are pleased to expand our capabilities in process research and manufacturing into the potent compound arena, and provide our partners with cost-effective and quality-driven means for undertaking this type of work in China," states Dr. Hao Hong, CEO of Asymchem.
Asymchem seeks to be a leader among Chinese-located manufacturing operations not only in facility design but also worker safety, and the
Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14-yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.
SOURCE Asymchem Laboratories
Source: PR Newswire
Related Articles
- China BAK Clarifies Investment Plan on Tianjin Facility
- SurModics Acquires Drug Delivery Assets From PR Pharmaceuticals
- FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
- CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China
- Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry Report Now Available
- Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
- Midwest Research Institute's Kansas City Facility Receives ISO 9001:2000 Certification
- Intec Pharma Collaborates With BioEnvelop and Tapemark - Gears Up Large-Scale Manufacturing of SuperGeneric Drugs Using Accordion Pill(TM) Gastric Retention Technology
- Trane Opened Its 2nd China Production Facility in Zhongshan
User Comments (0)


RSS Feeds